58 total views, 1 views today
Rwanda has received the first shipment of COVID-19 vaccines comprised of 240,000 AstraZeneca doses as the second shipment of 102,960 doses of the Pfizer vaccine, also from the COVAX facility is expected to arrive the same day in the evening.
With each recipient receiving two doses for full protection, the Ministry of Health said the AstraZeneca-Oxford and Pfizer vaccines will be used to vaccinate a total of 171,480 people identified as priority risk groups, including health personnel, those above 65 years old or with underlying health conditions, and other frontline workers.
“We are pleased to receive these first AstraZeneca and Pfizer vaccines through the COVAX initiative, and appreciate the partnerships with the UN Family, GAVI, funders as well as manufacturers that have made this possible,” said the Minister of Health Dr. Daniel Ngamije.
“We will immediately roll out our prepared vaccination plan which will see target risk groups across Rwanda receive their first of two vaccine doses. Our target is to vaccinate 30% of our population by the end of 2021, and 60% by the end of 2022,” he added.
According to the Ministry of Health, on Thursday, the vaccines will be dispatched from the Rwanda Biomedical Center warehouse to District Hospitals and then onto all 508 health centres across Rwanda.
Vaccination exercises will take place on Friday in hospitals and health centres, and vaccine recipients will be invited though their respective Districts.
Minister Ngamije cautioned that those vaccinated should continue to observe COVID prevention measures, including wearing masks, physical distancing, avoiding crowded and closed spaces and ensuring hand hygiene.
The health minister also pointed out that the Government of Rwanda continues negotiations with multiple partners, including international organizations and other governments, to acquire additional vaccines that will cover more people in subsequent phases.